A migraine drug ad featuring Serena Williams got called out by the FDA
In This Story ABBV BMY NVS The U.S. Food and Drug Administration (FDA) reprimanded AbbVie ( ABBV ) over an ad for its migraine medication, Ubrelvy, that featured tennis star Serena Williams. Suggested Reading OpenAI's new ChatGPT that can 'think' is here Campbell's Soup has a 'tricky needle to thread' in rebranding without soup, analysts say Trump Media stock is on a massive losing streak Trump Media stock is on a losing streak CC Share Subtitles Off English Share this Video Facebook Twitter
din zilele anterioare